Angle updates on AstraZeneca development work and Eisai’s phase 2 pilot study
Angle Inc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample, has provided CTC analysis with its Parsortix-based HER2 assay …